Detail akcie Inogen online

Business Summary: Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Inogen Inc revenues decreased 16% to $315.7M. Net loss increased 22% to $102.4M. Revenues reflect U.S. revenue segment decrease of 18% to $226.3M, Non-U.S. revenue segment decrease of 12% to $89.4M. Higher net loss reflects General and administ increase of 95% to $71.5M (expense), Research and Development - Balancing increase of 46% to $18.3M (expense).